Science & Technology Review
|
2016, 34(11): 48-52
• Special Issues •
Analysis of VEGF antibody technology patents of roche
Full
ZHANG Chi1, ZHANG Yinghui2
Affiliations
1. Pharmacy and Biotech Examination Department, The Patent Office, State Intellectual Property Office of the P R C, Beijing 100088, China;
2. Patent Examination Administration Departmeng, The Patent Office, State Intellectual Property Office of the P R C, Beijing 100088, China
Published: 2016-06-13
doi: 10.3981/j.issn.1000-7857.2016.11.008
Outline
This paper analyzes the technical development route of bevacizumab and ranibizumab based on the vascular endothelial growth factor (VEGF) antibody related patent applications of Roche. The layout in China of the VEGF related patents of Roche is also analyzed. Based on the above analyses, the future trends and directions of the technical research and development of VEGF antibody technology are predicted.
Roche
/
VEGF antibody
/
patent analysis
张弛, 张颖慧.
罗氏公司血管内皮生长因子抗体技术专利分析.
科技导报,
2016
, 34
(11)
: 48
-52
.
DOI: 10.3981/j.issn.1000-7857.2016.11.008
ZHANG Chi, ZHANG Yinghui.
Analysis of VEGF antibody technology patents of roche[J].
Science & Technology Review,
2016
, 34
(11)
: 48
-52
.
DOI: 10.3981/j.issn.1000-7857.2016.11.008
Year 2016 volume 34 Issue 11
PDF
465
117
Cite this Article
BibTeX
Article Info
doi: 10.3981/j.issn.1000-7857.2016.11.008
- Receive Date:2016-05-17
- Online Date:2016-06-29
- Published:2016-06-13